2022
DOI: 10.1016/j.jgar.2022.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Predominance of ST8 and CC1/spa-t1784 methicillin-resistant Staphylococcus aureus isolates in Japan and their genomic characteristics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 32 publications
1
5
0
Order By: Relevance
“…However, with the increasing prevalence of HA-MRSA in different countries, MRSA prevalence also noted lower in many such as 4.6% from Germany (Sassmannshausen et al, 2016), 25% from Texas (Davis et al, 2004), 19.1% from Mexico (Hamdan-Partida et al, 2022, 15.1% from Australia (Coombs et al, 2022), and 26% from Italy (La Vecchia et al, 2022) are summarized in Table 1. Similar increasing and decreasing trend of MRSA prevalence from different countries also noted for CA-MRSA such as 79% from Japan (Ogura et al, 2022), 84.9% from Australia (Coombs et al, 2022), 64.7% from India (Alvarez-Uria and Reddy, 2012), 61% from Norway (Enger et al, 2022), and 44.3% from Iran (Tabandeh et al, 2022) with lower prevalence from Egypt (16%) (Mostafa et al, 2022), China [1.7% (Bi et al, 2018); 24% (Chen et al, 2022)], 7.3% from Gerorgia (Hidron et al, 2005), and 12.8% from Switzerland (Harbarth et al, 2005). This decline in the prevalence of HA-MRSA and CA-MRSA may be linked with better implementation national prevention measures.…”
Section: Prevalence Of Mrsasupporting
confidence: 74%
“…However, with the increasing prevalence of HA-MRSA in different countries, MRSA prevalence also noted lower in many such as 4.6% from Germany (Sassmannshausen et al, 2016), 25% from Texas (Davis et al, 2004), 19.1% from Mexico (Hamdan-Partida et al, 2022, 15.1% from Australia (Coombs et al, 2022), and 26% from Italy (La Vecchia et al, 2022) are summarized in Table 1. Similar increasing and decreasing trend of MRSA prevalence from different countries also noted for CA-MRSA such as 79% from Japan (Ogura et al, 2022), 84.9% from Australia (Coombs et al, 2022), 64.7% from India (Alvarez-Uria and Reddy, 2012), 61% from Norway (Enger et al, 2022), and 44.3% from Iran (Tabandeh et al, 2022) with lower prevalence from Egypt (16%) (Mostafa et al, 2022), China [1.7% (Bi et al, 2018); 24% (Chen et al, 2022)], 7.3% from Gerorgia (Hidron et al, 2005), and 12.8% from Switzerland (Harbarth et al, 2005). This decline in the prevalence of HA-MRSA and CA-MRSA may be linked with better implementation national prevention measures.…”
Section: Prevalence Of Mrsasupporting
confidence: 74%
“…More important CA-MRSA clones according to [ 2 , 23 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 ] are shown in Table 4 , most important HA-MRSA clones according to [ 23 , 85 , 125 , 220 , 224 , 233 , 234 , 235 , 236 ] are shown in Table 5 , and most important LA-MRSA clones according to [ 23 , 125 , 237 , 238 , 239 , 240 , 241 , 242 ] are shown in Table 6 .…”
Section: Molecular Epidemiology Of Mrsamentioning
confidence: 99%
“…For example, a report on MRSA isolated from 13 hospitals in Tokyo and surrounding prefectures showed that the SCCmec type IV/CC1 clone was most frequently detected and possessed sea. 13 In a neonatal intensive care unit in Shizuoka, 86.0% of MRSA isolates exhibited SCCmec type IV/CC1 and were all resistant to new quinolones. 19 Recently, a regional outbreak of SCCmec type IV/CC1 (ST2725) MRSA was reported in Niigata.…”
Section: Discussionmentioning
confidence: 99%
“…The USA300 clone (SCCmec type IV/ST8), prevalent in the United States, carries the PVL gene (lukS/F-PV). 10,[13][14][15] Because each clone possesses different and characteristic virulence genes, all MRSA isolates were analyzed for the SCCmec type and screened for the presence of tst, sea, seb, sec, and lukS/F-PV using PCR, as previously reported. 16,17 MLST was performed on all isolates using previously reported primers.…”
Section: Study Definitionsmentioning
confidence: 99%